These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7742288)

  • 1. Microbial contamination of medications used to treat glaucoma.
    Geyer O; Bottone EJ; Podos SM; Schumer RA; Asbell PA
    Br J Ophthalmol; 1995 Apr; 79(4):376-9. PubMed ID: 7742288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of in-use ocular medications.
    Schein OD; Hibberd PL; Starck T; Baker AS; Kenyon KR
    Arch Ophthalmol; 1992 Jan; 110(1):82-5. PubMed ID: 1731727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital.
    Teuchner B; Wagner J; Bechrakis NE; Orth-Höller D; Nagl M
    Medicine (Baltimore); 2015 Feb; 94(8):e583. PubMed ID: 25715262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of multi-use ophthalmic solutions in Kenya.
    Nentwich MM; Kollmann KH; Meshack J; Ilako DR; Schaller UC
    Br J Ophthalmol; 2007 Oct; 91(10):1265-8. PubMed ID: 17475714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial contamination of ophthalmic solutions used in an extended care facility.
    Jokl DH; Wormser GP; Nichols NS; Montecalvo MA; Karmen CL
    Br J Ophthalmol; 2007 Oct; 91(10):1308-10. PubMed ID: 17475711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterility of glaucoma medications among chronic users in the community.
    Porges Y; Rothkoff L; Glick J; Cohen S
    J Ocul Pharmacol Ther; 2004 Apr; 20(2):123-8. PubMed ID: 15117568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles.
    Høvding G; Sjursen H
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):213-22. PubMed ID: 6753455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bacterial contamination of three multidose ophthalmic solutions.
    Betbeze CM; Stiles J; Krohne SG
    Vet Ophthalmol; 2007; 10(2):81-3. PubMed ID: 17324162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing.
    Stevens JD; Matheson MM
    Br J Ophthalmol; 1992 Jan; 76(1):36-8. PubMed ID: 1739689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic topical glaucoma medications on aerobic conjunctival bacterial flora.
    Sen EM; Yilmaz MB; Dansuk Z; Aksakal FN; Altinok A; Tuna T; Koklu G
    Cornea; 2009 Apr; 28(3):266-70. PubMed ID: 19387226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia.
    Tsegaw A; Tsegaw A; Abula T; Assefa Y
    Middle East Afr J Ophthalmol; 2017; 24(2):81-86. PubMed ID: 28936051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival and corneal sensitivity in patients under topical antiglaucoma treatment.
    Romero-Díaz de León L; Morales-León JE; Ledesma-Gil J; Navas A
    Int Ophthalmol; 2016 Jun; 36(3):299-303. PubMed ID: 26272426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops.
    Ohtani S; Shimizu K; Nejima R; Kagaya F; Aihara M; Iwasaki T; Shoji N; Miyata K
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3991-3996. PubMed ID: 28796877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical antiglaucoma medications and lacrimal drainage system obstruction.
    Kashkouli MB; Rezaee R; Nilforoushan N; Salimi S; Foroutan A; Naseripour M
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):172-5. PubMed ID: 18520829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.
    Al-Jumaian N; Malik R; Khandekar R; Al-Humaidan A; Al-Madany R; Al-Qahtani R; Altowairqi A; Al-Theeb A; Zaman B; Al-Djasim L; Craven ER; Edward DP
    Middle East Afr J Ophthalmol; 2016; 23(4):296-301. PubMed ID: 27994392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An objective assessment of the variability in number of drops per bottle of glaucoma medication.
    Moore DB; Beck J; Kryscio RJ
    BMC Ophthalmol; 2017 May; 17(1):78. PubMed ID: 28532424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of eyedrop dispensers.
    Coad CT; Osato MS; Wilhelmus KR
    Am J Ophthalmol; 1984 Nov; 98(5):548-51. PubMed ID: 6437230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in preservative-free glaucoma drops].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the association between patterns of eye drop prescription and medication usage in glaucoma subjects.
    Kawai-Tsuboi N; Kawai M; Minami Y; Yoshida A
    J Glaucoma; 2015 Mar; 24(3):202-6. PubMed ID: 23807351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.